IFNGR2

AS101 : Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway

Torin 2 : Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy

Nitazoxanide : Intestinal protozoa and helminths in ulcerative colitis and the influence of anti-parasitic therapy on the course of the diseas

Danuglipron: Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists

Pictilisib: A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced nonesmall cell lung cancer

Nab-Paclitaxel : Nab-paclitaxel Monotherapy for Relapsed Small Cell Lung Cancer: Retrospective Analysis and Review

LY2880070: Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer

Cpd 20m : ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy